Drugs / Amara Drops
Amara Drops
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05553587 | Jul 2022 → Feb 2025 | dyspepsia | Mark Fox | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amara Drops | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05553587 ↗ |
| Known as | Amara tincture | “Amara tincture (Weleda, Arlesheim, Switzerland) is a proprietary preparation used for many decades in complementary medicine that is marketed for the treatment of functional...” NCT05553587 ↗ |
| Known as | Weleda Amara-Drops | “Weleda Amara-Drops can be used for digestive complaints such as heartburn, flatulence and bloating after meals, to stimulate the bile flow and for loss of appetite and nausea.” NCT05553587 ↗ |
| Route | Oral | “Amara Drops will be dispensed with 10-20 drops (0.25-0.50ml) taken three times a day prior to meals for 4 weeks.” NCT05553587 ↗ |